Cytokinetics falls after announcing $550 mln convertible bonds offering
** Cytokinetics' CYTK.O shares down 3.3% in extended trading to $48.10 as biotech firm looks to raise capital
** South San Francisco, California-based CYTK announces private offering of $550 mln 6-yr convertible bonds (CBs)
** Co plans to use net offering proceeds to support potential commercial launch of its heart disease drug, aficamten, expand the drug's development program, among other uses
** It also intends to use portion of proceeds to issue shares in exchange for a portion of its outstanding 3.5% CBs due 2027 in negotiated transactions
** On Sept 2, CYTK shares soared ~40% to close at $49.62 after co said aficamten outperformed standard-of-care treatment, metoprolol
** Co has roughly $6 bln market cap, based on ~119.7 mln shares outstanding
** Shares on Tues ended up 0.6% at $49.76, up nearly 6% YTD
** Of 20 analysts covering CYTK, recommendation breakdown is 16 "strong buy" or "buy" and 4 "hold"; median PT is $74, per LSEG data
Related Articles
September Fed Watch: A Policy Pivot That Could Make or Break the Bull Stock Market
TradingKey - The Fed’s September FOMC meeting is widely seen as locking in the first rate cut of 2025. Yet strategists at Morgan Stanley, JPMorgan, and Oppenheimer warn that as investors shift focus to slowing growth, a more cautious tone may replace bullish stock sentiment.
Meta Connect 2025: An Inflection Point for AR Wearables?
TradingKey - Meta Connect 2025 kicks off this Wednesday, and expectations couldn’t be higher.
Effects of Interest Rate Cuts: Impact of Fed's September Meeting on Crypto Market
The Fed’s rate cut decision is a major bullish catalyst for crypto — but it comes with uncertainty. Investors should understand the economic rationale behind the move and adjust strategies accordingly. Staying flexible, informed, and disciplined is key to thriving in crypto’s fast-moving environment
Japan Q2 GDP Commentary: Growth Revised Upward, Yen May Rise
TradingKey - On 8 September 2025, Japan released the revised Q2 GDP figures. The data showed that real GDP grew by 0.5% quarter-on-quarter, surpassing market expectations of 0.3% and the previous quarter’s 0% growth.
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
